Skip to main content

Unique Perfusion Imaging (r)evolution. Discover our Complete Solution

Cercare Perfusion uniquely provides maps reflecting oxygen availability, in addition to blood flow and volume.

Our patented Biomarkers allow a more detailed assessment of tissue pathology and therefore optimized patient management for a variety of indications, such as Stroke, Oncology, Alzheimer, Dementia, Neoplasia, COVID-19…

Cercare Perfusion uses AI for the stroke lesion detection module, which segments the hypoperfusion and core regions of acute ischemic stroke.

CTH (Capillary Transit Heterogeneity), OEF ( Oxygen Extraction Fraction), and CMRO2 (Cerebral Rate Of O2): Inspect microvascular conditions to elaborate the final interpretation and match with clinical symptoms.

Change Nothing, Get More.Discover our Complete Solution

Gain time and High-level expertise in perfusion imaging for precise, fast, and reliable care without any change in your workflow.

From the field.

  • Cercare Medical News: Revolutionizing Stroke Care: Cercare Medical Debuts CMN Version 14
    Learn more
  • Cercare Medical News: Celebrating Innovative Collaboration with Fondation Rothschild Hospital
    Learn more
  • Meet us @Billeddiagnostisk Årsmøde 2024
    Learn more

Users of Cercare Perfusion.

“The perfusion derived maps help us to quantitatively assess lesion progression of adrenoleukodystrophy patients in an ongoing clinical trial. We envision that this work will enable more personalized and timely treatment options for our patients”

Patricia L. Musolino, MGH-Harvard Medical School

Assistant Professor of Neurology

“We are impressed with Cercare’s Perfusion software, due to its ease of use, reliability and speed, thanks to its fully automated post processing”

Tobias Granberg, Karolinska Institutet
Associate Professor


  • Cercare Perfusion: A Novel Approach to Perfusion Imaging Technology for Oncology Assessment
    Learn more
  • Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
    Learn more
  • Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps
    Learn more
  • Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma
    Learn more

Partners & Platform.

  • logo
  • Siemens logo
  • Terarecon logo

Take part in Perfusion (r)evolution!